CD8A and neoplasm: In PDAC, the immunosuppressive effects of these protumor TAMs arise from their ability to inhibit the antitumor activity of CD8+ cytotoxic T lymphocytes by upregulating PD-L1 expression in tumor cells and depleting essential nutrients required by T cells [93].